ATE239713T1 - Verfahren zur herstellung von alkoxyfuranon-amin- derivaten, durch dieses verfahren erhaltene verbindungen und verwendung dieser verbindungen - Google Patents
Verfahren zur herstellung von alkoxyfuranon-amin- derivaten, durch dieses verfahren erhaltene verbindungen und verwendung dieser verbindungenInfo
- Publication number
- ATE239713T1 ATE239713T1 AT98937591T AT98937591T ATE239713T1 AT E239713 T1 ATE239713 T1 AT E239713T1 AT 98937591 T AT98937591 T AT 98937591T AT 98937591 T AT98937591 T AT 98937591T AT E239713 T1 ATE239713 T1 AT E239713T1
- Authority
- AT
- Austria
- Prior art keywords
- compounds
- alkoxyfuranone
- producing
- amine derivatives
- compounds obtained
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B57/00—Separation of optically-active compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/60—Two oxygen atoms, e.g. succinic anhydride
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9708932A FR2766188B1 (fr) | 1997-07-15 | 1997-07-15 | Nouveau procede de preparation de derives amines d'alkyloxy furanone, composes issus de ce procede et utilisation de ces composes |
| PCT/FR1998/001480 WO1999003852A1 (fr) | 1997-07-15 | 1998-07-09 | Procede de preparation de derives amines d'alkyloxyfuranone, composes issus de ce procede et utilisation de ces composes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE239713T1 true ATE239713T1 (de) | 2003-05-15 |
Family
ID=9509210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98937591T ATE239713T1 (de) | 1997-07-15 | 1998-07-09 | Verfahren zur herstellung von alkoxyfuranon-amin- derivaten, durch dieses verfahren erhaltene verbindungen und verwendung dieser verbindungen |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US6235899B1 (de) |
| EP (1) | EP0998470B1 (de) |
| JP (1) | JP4450987B2 (de) |
| KR (1) | KR100519691B1 (de) |
| CN (1) | CN100363355C (de) |
| AP (1) | AP1071A (de) |
| AR (1) | AR015924A1 (de) |
| AT (1) | ATE239713T1 (de) |
| AU (1) | AU744272B2 (de) |
| BG (1) | BG64050B1 (de) |
| BR (1) | BR9810896A (de) |
| CA (1) | CA2296742C (de) |
| CZ (1) | CZ295312B6 (de) |
| DE (1) | DE69814395T2 (de) |
| DK (1) | DK0998470T3 (de) |
| EA (1) | EA002883B1 (de) |
| EE (1) | EE03873B1 (de) |
| ES (1) | ES2197489T3 (de) |
| FR (1) | FR2766188B1 (de) |
| HR (1) | HRP20000027B1 (de) |
| HU (1) | HU230148B1 (de) |
| ID (1) | ID23784A (de) |
| IL (1) | IL134031A (de) |
| ME (1) | ME01708B (de) |
| NO (1) | NO324508B1 (de) |
| NZ (1) | NZ502338A (de) |
| PL (1) | PL200820B1 (de) |
| PT (1) | PT998470E (de) |
| RS (1) | RS49832B (de) |
| SK (1) | SK284168B6 (de) |
| TR (1) | TR200000117T2 (de) |
| UA (1) | UA66364C2 (de) |
| WO (1) | WO1999003852A1 (de) |
| ZA (1) | ZA986203B (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7053056B2 (en) * | 1998-07-02 | 2006-05-30 | Idun Pharmaceuticals, Inc. | C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| AU5369201A (en) * | 2000-04-24 | 2001-11-07 | Vertex Pharma | Process and intermediates for making substituted aspartic acid acetals |
| PE20011350A1 (es) | 2000-05-19 | 2002-01-15 | Vertex Pharma | PROFARMACO DE UN INHIBIDOR DE ENZIMA CONVERTIDORA DE INTERLEUCINA-1ß (ICE) |
| JP2003327568A (ja) * | 2000-09-20 | 2003-11-19 | Kanegafuchi Chem Ind Co Ltd | 光学活性β−アミノ酸誘導体の製造方法 |
| JPWO2002055478A1 (ja) * | 2001-01-16 | 2004-05-13 | 鐘淵化学工業株式会社 | 光学活性アミノラクトン誘導体の製造法およびその中間体 |
| CN102161656B (zh) | 2004-02-27 | 2013-02-20 | 沃泰克斯药物股份有限公司 | 天冬氨酸特异性半胱氨酸蛋白酶抑制剂及其用途 |
| CN103467459A (zh) | 2004-03-12 | 2013-12-25 | 弗特克斯药品有限公司 | 制备化合物的方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6204261B1 (en) * | 1995-12-20 | 2001-03-20 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β Converting enzyme inhibitors |
| US5716929A (en) * | 1994-06-17 | 1998-02-10 | Vertex Pharmaceuticals, Inc. | Inhibitors of interleukin-1β converting enzyme |
-
1997
- 1997-07-15 FR FR9708932A patent/FR2766188B1/fr not_active Expired - Lifetime
-
1998
- 1998-07-09 AT AT98937591T patent/ATE239713T1/de active
- 1998-07-09 RS YUP-15/00A patent/RS49832B/sr unknown
- 1998-07-09 ME MEP-2000-15A patent/ME01708B/me unknown
- 1998-07-09 JP JP2000503076A patent/JP4450987B2/ja not_active Expired - Lifetime
- 1998-07-09 ID IDW20000067A patent/ID23784A/id unknown
- 1998-07-09 KR KR10-2000-7000398A patent/KR100519691B1/ko not_active IP Right Cessation
- 1998-07-09 EE EEP200000024A patent/EE03873B1/xx unknown
- 1998-07-09 HU HU0003857A patent/HU230148B1/hu unknown
- 1998-07-09 EP EP98937591A patent/EP0998470B1/de not_active Expired - Lifetime
- 1998-07-09 AP APAP/P/2000/001732A patent/AP1071A/en active
- 1998-07-09 PL PL338035A patent/PL200820B1/pl unknown
- 1998-07-09 BR BR9810896-4A patent/BR9810896A/pt not_active Application Discontinuation
- 1998-07-09 NZ NZ502338A patent/NZ502338A/en not_active IP Right Cessation
- 1998-07-09 CZ CZ200065A patent/CZ295312B6/cs not_active IP Right Cessation
- 1998-07-09 ES ES98937591T patent/ES2197489T3/es not_active Expired - Lifetime
- 1998-07-09 AU AU86333/98A patent/AU744272B2/en not_active Expired
- 1998-07-09 EA EA200000127A patent/EA002883B1/ru not_active IP Right Cessation
- 1998-07-09 DE DE69814395T patent/DE69814395T2/de not_active Expired - Lifetime
- 1998-07-09 IL IL13403198A patent/IL134031A/en not_active IP Right Cessation
- 1998-07-09 CA CA002296742A patent/CA2296742C/fr not_active Expired - Lifetime
- 1998-07-09 WO PCT/FR1998/001480 patent/WO1999003852A1/fr active IP Right Grant
- 1998-07-09 DK DK98937591T patent/DK0998470T3/da active
- 1998-07-09 CN CNB98808967XA patent/CN100363355C/zh not_active Expired - Lifetime
- 1998-07-09 US US09/463,014 patent/US6235899B1/en not_active Expired - Lifetime
- 1998-07-09 TR TR2000/00117T patent/TR200000117T2/xx unknown
- 1998-07-09 PT PT98937591T patent/PT998470E/pt unknown
- 1998-07-09 SK SK30-2000A patent/SK284168B6/sk not_active IP Right Cessation
- 1998-07-13 ZA ZA9806203A patent/ZA986203B/xx unknown
- 1998-07-15 AR ARP980103455A patent/AR015924A1/es not_active Application Discontinuation
- 1998-09-07 UA UA2000020800A patent/UA66364C2/uk unknown
-
2000
- 2000-01-12 BG BG104073A patent/BG64050B1/bg unknown
- 2000-01-14 HR HR20000027A patent/HRP20000027B1/xx not_active IP Right Cessation
- 2000-01-14 NO NO20000182A patent/NO324508B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69320805D1 (de) | Verfahren zur herstellung von cyclopentadien-metallkomplex verbindungen und verfahren zur verwendung | |
| ATE360608T1 (de) | Verfahren zur herstellung von 1,3-diolen | |
| DE59706114D1 (de) | Verfahren zur herstellung von 1,4-butandiol durch katalytische hydrierung von 1,4-butindiol | |
| DE69413727D1 (de) | Verfahren zur Herstellung von Kohlenstoffdioxid-Absorptionsmittel durch Verwendung von Betonschlamm | |
| DE68907320D1 (de) | Verfahren zur herstellung von modifizierten polypropylen-zusammensetzungen. | |
| DE69830659D1 (de) | Leitgährige zusammensetzung,verbundstoff dafür und verfahren zur herstellung dieser zusammensetzung und dieses verbundstoffes | |
| DE69427540D1 (de) | Verfahren zur herstellung von sufentanil derivaten durch carbene addition/aminolyse von 4-piperidon | |
| DE69407624D1 (de) | Verfahren zur herstellung von sialon-verbundwerkstoffen | |
| DE69841108D1 (de) | Verfahren zur herstellung von siliziumkarbideinkristallen | |
| DE69504196D1 (de) | Verfahren zur herstellung von siliciumcarbid | |
| DE69900546D1 (de) | Verfahren zur herstellung von gamma-butyrolacton | |
| DE69533582D1 (de) | Verfahren zur herstellung von wasserstoffcyanid | |
| DE3676683D1 (de) | Mischung von derivaten von aminosaeuren, verfahren zur herstellung der mischung und verwendung der mischung zur mengenbestimmung der aminosaeuren. | |
| DE59611017D1 (de) | Verfahren zur herstellung von n-substituierten 3-hydroxypyrazolen | |
| DE69607344D1 (de) | Verfahren zur herstellung von n,n'-disubstituierten cyclischen harnstoffen | |
| ATE325788T1 (de) | Kristalle von vitamin d derivaten und verfahren zu ihrer herstellung | |
| DE69628203D1 (de) | Verfahren zur herstellung von phenylimidazolin-derivaten | |
| ATA294087A (de) | Verfahren zur herstellung von 5,6-dihydroxyindol und dessen 3-alkylderivat, zwischenverbindungen und verwendung | |
| DE69709655D1 (de) | Verfahren zur herstellung von 17-estern von 9alpha,21-dihalopregan-11beta,17alpha-diol-20-onen | |
| DE69814395D1 (de) | Verfahren zur herstellung von alkoxyfuranon-amin-derivaten, durch dieses verfahren erhaltene verbindungen und verwendung dieser verbindungen | |
| DE69522807D1 (de) | Verfahren zur herstellung von feinkörnigen, modifizierten stärken | |
| DE59807503D1 (de) | Verfahren zur herstellung von erdalkalidiorganylverbindungen | |
| ATE226198T1 (de) | Ein verfahren zur herstellung von tetraaza makrocyclen | |
| ATE214686T1 (de) | Verfahren zur herstellung von fluorverbindungen aus den entsprechenden aminen | |
| ATE366251T1 (de) | Verfahren zur herstellung von 1,3- disubstituierten-4-oxocyclischen harnstoffen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0998470 Country of ref document: EP |